Please login to the form below

Not currently logged in
Email:
Password:

Sanofi appoints immunology and inflammation research global head

Dr Frank Nestle also becomes North America chief scientific officer

Sanofi Dr Frank NestleSanofi has appointed Dr Frank Nestle as both the global head of immunology and inflammation research therapeutic area and North America chief executive officer.

Based out of the French firm's Cambridge, Massachusetts office, Dr Nestle will be responsible for developing Sanofi's early stage immunology and inflammations portfolio and driving its scientific intelligence across multiple therapeutic areas in the US.

He joins Sanofi from King's College London, where he was the Mary Dunhill professor and chair of cutaneous medicine and immunotherapy.

Currently, Dr Nestle serves as lead biomarker for the co-diagnostics, imaging and devices cluster at the Biomedical Research Centre and is the outgoing president of the Federation of Clinical Immunology Societies.

He is a fellow of the Academy of Medical Sciences, a senior investigator emeritus at the National Institute for Health Research and has also served as a non-executive director at Guy's and St Thomas' Foundation Trust Hospital.

12th September 2016

From: Research

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Bedrock Healthcare Communications

Founded in 2011, Bedrock Healthcare Communications is a privately owned, award winning communications agency that creates and delivers highly effective,...

Latest intelligence

Cell and gene therapies: on course for commercial success?
...
eyeforpharma_h_logo.png
Make Anthill your strategic partner in Barcelona
We are excited to attend and exhibit at eyeforpharma Barcelona 2017 (March 14-16th), and present two multichannel strategy workshops....
Why we need to bring empathy back into medcomms
Medical communications requires you to bring more empathy to your communications...

Infographics